ArticleClinical epigenetics2019

Increased methylation upstream of the MEG3 promotor is observed in acute myeloid leukemia patients with better overall survival.

Zachariah Payne Sellers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.